Egetis Therapeutics AB (publ) (EGTX) — Capital Reinvestment Ratio

Latest as of June 2011: 1.30x

Egetis Therapeutics AB (publ) (EGTX) has a Capital Reinvestment Ratio of 1.30x as of June 2011, meaning it reinvests 1% of its operating cash flow (Skr1.84 Million) in capital expenditures (Skr2.38 Million). See debt-free asset ratio of Egetis Therapeutics AB (publ) to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

1.30x

Capex / Operating Cash Flow

Operating Cash Flow

Skr1.84 Million

SEK

Capital Expenditures

Skr2.38 Million

SEK

Data as of

Jun 2011

Most recent filing

Annual Capital Reinvestment Ratio for Egetis Therapeutics AB (publ) (None–None)

Year-by-year Capital Reinvestment Ratio for Egetis Therapeutics AB (publ) from None to None. For live market cap and broader valuation context, see how much is Egetis Therapeutics AB (publ) worth.

Year	Reinvestment Ratio	Operating CF (SEK)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow